FDA vs EFSA 2026: Where the Same Supplement Claim Is Allowed — and Where It Isn’t
If you import supplements from China, the FDA and FSVP rules you meet at the border are only half the story — the claim rules in your target market decide what you can actually print. After twenty-plus years in this supply chain, the pattern I see constantly is a buyer who locks a formula in one market and assumes the same words clear the next. (I’m not a lawyer; this isn’t legal advice.)
The one rule both markets agree on (claims need substantiation)
Strip away the structure and the two systems share a foundation:
- No disease claims for supplements. Neither the US FDA nor the EU EFSA permits a supplement to make disease claims — those are reserved for approved drugs. That line is firm on both sides of the Atlantic.
- Claims must be truthful and backed by evidence. In the US this falls under FTC Act truth-in-advertising; in the EU it’s built into Reg (EC) 1924/2006. “We feel confident about it” is not substantiation.
- The burden sits with the brand. You, not the supplier, are expected to hold the evidence that the claim is permitted and supportable in the market where you sell.
Where they diverge is how a claim gets cleared to print — one market is largely self-affirmed, the other is pre-listed.
US structure/function vs EU authorized list — side-by-side
| Dimension | United States (FDA / FTC) | European Union (EFSA / Commission) |
|---|---|---|
| Legal frame | Dietary Supplement Health and Education Act; FTC Act | Reg (EC) 1924/2006 on nutrition and health claims |
| Claim type allowed | “Structure/function” claims (e.g., “supports ___”) | Only claims in the authorized register |
| Pre-approval needed? | No pre-approval for structure/function; NDI notification for new ingredients | Yes — claim must be authorized before use |
| Who assesses | Brand self-substantiates; FDA can challenge | EFSA assesses, Commission authorizes a listed claim |
| Standard disclaimer | “These statements have not been evaluated by the FDA…” | No equivalent; claim must already be on the list |
| Generic “wellness” wording | Tolerated if framed as structure/function | Not permitted unless the exact wording is authorized |
The practical takeaway: in the US you can often use a carefully worded structure/function claim if you hold substantiation; in the EU you must use a claim that already exists in the authorized register, in (or closely matching) the approved wording. A phrase that’s merely “reasonable” in the US can be simply unlawful in the EU.
Three claims that pass in one market and fail in the other
These are illustrative contrasts, not an exhaustive list — and the exact wording always decides it.
1. “Supports a healthy heart.” In the US this reads as a classic structure/function claim. With substantiation on file and the standard disclaimer, it’s generally workable. In the EU, “healthy heart” is not a free-form phrase; a heart-related claim is only usable if an authorized entry exists and your wording matches it. Use a looser version and it fails.
2. “Helps maintain cholesterol levels already in the normal range.” In the US this kind of targeted structure/function wording is commonly seen. In the EU, cholesterol-related claims are tightly controlled — only specific authorized claims (for example, those tied to defined ingredients like plant sterols) are permitted, and the wording is fixed. A self-written version, however reasonable it sounds, is not automatically allowed.
3. Antioxidant wording. In the US, “provides antioxidant support” can function as a structure/function claim with substantiation. In the EU, “antioxidant” is a defined nutrition claim with conditions attached; using it loosely, or applying it to an ingredient not meeting the condition, fails the authorized-list test.
The lesson isn’t “the EU is stricter” as a moral point — it’s that the mechanism differs. One is about holding evidence; the other is about matching a published list. Both are checkable on paper before you print.
What documents prove a supplement claim is permitted?
Buyers often ask me for “the certificate that says I can say this.” The honest answer is that it depends on the market:
- US — substantiation file. There’s no stamped permission slip. You hold the studies, the rationale, and (for new dietary ingredients) an NDI notification where required. The proof is your documentation that the claim is truthful and substantiated.
- EU — the authorized register entry. The proof is the claim appearing in the EU register of permitted health and nutrition claims, with wording that matches your label. EFSA’s assessment and the Commission’s authorization are the backbone; your job is to find your claim there and use it verbatim.
- Both — the supplier’s certificate is not the proof. A Chinese factory can print whatever you ask on a label; that doesn’t make it permitted where you sell. The document that matters lives in your market’s framework, not the supplier’s.
This is exactly why I tell clients to decide target markets before briefing the formula — the claim rules quietly shape the formula, the label, and the timeline.
What should you check before briefing a formula for import?
Run this before you finalize wording with a supplier:
- Have I named every target market? A claim allowed in one can be barred in another; expansions get forgotten.
- For the US: do I hold substantiation for each structure/function claim, and is the standard disclaimer in place?
- For the EU: is each claim in the authorized register, and does my wording match it exactly?
- Have I separated “what the supplier can print” from “what my market permits”? They are not the same thing.
- Is the formula itself permitted at my intended strength in each market? Claim rules and ingredient rules are two different checks.
Fixing a claim mismatch at the brief stage costs an afternoon. Fixing it after a run is printed or a shipment is booked costs a reorder. If you want the broader pre-sourcing checklist that catches this earlier, the berberine form-and-COA article shows how one ingredient’s spec already carries claim implications — and the factory-vs-trader case file shows what happens when paperwork is taken at face value.
Related guides
- 5 Myths About Chinese Supplement Factories
- Case File: The ‘Factory’ That Was a Trading Company
- Berberine Sourcing From China: Forms, COAs & What ‘99%’ Means
Frequently asked questions
When I import supplements from China, what does the FDA’s FSVP actually require?
Not structure/function claims. A brand can use them without pre-approval, but must hold substantiation and include the standard “not evaluated by the FDA” disclaimer. New dietary ingredients follow a separate notification route. The FDA and FTC can challenge claims that aren’t truthful or well-supported, so the responsibility sits with the brand, not with a pre-clearance stamp.
What is the EU authorized claims list?
It’s the register of health and nutrition claims permitted under Reg (EC) 1924/2006, built on EFSA assessments and Commission authorization. A claim is usable in the EU only if it appears there and your label wording matches the approved form. Generic or self-written wellness phrasing isn’t permitted just because it sounds reasonable.
If a claim is allowed in the US, is it allowed in the EU?
Not necessarily. The US leans on self-substantiated structure/function claims; the EU requires the exact claim to be on the authorized list. The same idea can be printable in one market and unlawful in the other, which is why target markets should be fixed before the formula and label are briefed.
Found this useful? The free China Sourcing Pitfall Guide walks through the 9 steps and the 5 costly mistakes buyers meet when sourcing from China — including locking your target-market claim rules before you brief a formula. Get the Free China Sourcing Pitfall Guide